Ebola treatment trial begins in DRC amid $3.6B outbreak cost warning

A clinical trial for Ebola treatments has commenced in the Democratic Republic of Congo as the outbreak continues. The UN has estimated the outbreak could cost Africa up to $3.6 billion in economic impact, elevating the health crisis's significance for businesses and investors operating across affected regions.

📈 Clinical trials of Ebola treatments have formally begun in DRC as the UN's $3.6B economic impact warning provides macro health-risk context for investors.